Literature DB >> 9588883

Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.

H Miyake1, I Hara, K Yamanaka, K Gohji, S Arakawa, S Kamidono.   

Abstract

Despite recent extensive immunohistochemical studies, the expression patterns of CD44 in testicular germ cell tumors are still controversial. In the present study, we investigated the CD44 gene expression in 40 specimens including 18 seminomas, 16 nonseminomatous germ cell tumors (NSGCT), and 6 normal testes by reverse transcriptase-polymerase chain reaction and Western blotting. Reverse transcriptase-polymerase chain reaction analysis revealed that the standard CD44 isoform (CD44s) was expressed in all of the specimens, whereas the variant CD44 isoforms were highly expressed in NSGCTs but barely detectable in seminomas and normal testes. In addition, we confirmed by direct DNA sequence analysis that the predominantly expressed variant isoform in NSGCTs was CD44v8-10. In germ cell tumors, these results were paralleled in Western blot analysis; that is, CD44s protein was expressed in all of the tumor specimens, whereas high molecular weight variant isoforms were expressed only in NSGCTs. However, at the protein level, no detectable CD44 was expressed in normal testes. These findings show that the combined assessment of CD44 expression patterns at both the RNA and protein levels enables us to distinguish among seminoma, NSGCT, and normal testis specimens; hence, it could serve as a useful practical adjunct to conventional diagnostic methods for testicular germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588883      PMCID: PMC1858567     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44.

Authors:  M Birch; S Mitchell; I R Hart
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.

Authors:  I Okamoto; T Morisaki; J Sasaki; H Miyake; M Matsumoto; M Suga; M Ando; H Saya
Journal:  J Natl Cancer Inst       Date:  1998-02-18       Impact factor: 13.506

4.  Splicing choice from ten variant exons establishes CD44 variability.

Authors:  C Tölg; M Hofmann; P Herrlich; H Ponta
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

5.  Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.

Authors:  K K Tanabe; T Nishi; H Saya
Journal:  Mol Carcinog       Date:  1993       Impact factor: 4.784

6.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

7.  Glycoprotein CD44 expression and its association with survival in breast cancer.

Authors:  H Joensuu; P J Klemi; S Toikkanen; S Jalkanen
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

8.  Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

Authors:  S B Fox; J Fawcett; D G Jackson; I Collins; K C Gatter; A L Harris; A Gearing; D L Simmons
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

9.  CD44 variant exon epitopes in primary breast cancer and length of survival.

Authors:  M Kaufmann; K H Heider; H P Sinn; G von Minckwitz; H Ponta; P Herrlich
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

10.  Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

Authors:  A Bartolazzi; R Peach; A Aruffo; I Stamenkovic
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  2 in total

1.  TRA-1-60+, SSEA-4+, POU5F1+, SOX2+, NANOG+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes.

Authors:  Marek Malecki; Xenia Tombokan; Mark Anderson; Raf Malecki; Michael Beauchaine
Journal:  J Stem Cell Res Ther       Date:  2013-04-02

2.  Esrp1 is a marker of mouse fetal germ cells and differentially expressed during spermatogenesis.

Authors:  Shaghayegh Saeidi; Farnaz Shapouri; Robb U de Iongh; Franca Casagranda; Jessie M Sutherland; Patrick S Western; Eileen A McLaughlin; Mary Familari; Gary R Hime
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.